Flumazenil USP assay with HPLC - INTERNAL ONLY
October 27, 2022
/
/
/
/
/
/
/
CONFIDENTIAL – INTERNAL ONLY. Click here for public AppNote.

Alternate L1 column used for a similar USP assay method of Flumazenil

This Similar USP Flumazenil is easily performed and the 10 injection overlay below demonstrates run to run consistency and great peak symmetry. The peak efficiency is very good and peak tailing guidelines are easily met with RSD values of less than 1.0%.

This demonstrates a good alternate column for your Flumazenil USP method.



Peak:
Flumazenil

Method Conditions:
Column: Cogent RP C18™, 5um, 100Å

Catalog No.: 68518-15P
Dimensions: 4.6mm x 150mm
Solution A: 800 mL of water, adjusted with phosphoric acid to a pH of 2.0 ± 0.05

Mobile phase: Methanol, tetrahydrofuran, and Solution A (13:7:80)
Flow rate: 1.0mL / minute
Detection: UV @ 230nm
Sample Preparation: 1.0 mg/mL of Flumazenil in Mobile phase
Tailing factor: NMT 1.5
Relative standard deviation: NMT 2.0%


Note 1: For the full method conditions and details, consult the official United States Pharmacopeia–National Formulary (USP–NF.)
Note 2: Flumazenil is a GABA receptor antagonist and can treat drowsiness caused by sedatives following surgery or drug overdose.


.

© Copyright 2025. MICROSOLV. All Rights Reserved. Website & Hosting by BlueTone Media